TABLE 3.

Biologics for medicare patients, mode of delivery and recommended dosing

BIOLOGIC AGENT	ADMINISTRATION ROUTE	INITIAL DOSING	MAINTENANCE DOSING
Tildrakizumab	Subcutaneous	100mg at Weeks 0 and 4	100mg every 12 weeks
Infliximab	Intravenous	5mg/kg at Weeks 0, 2, and 6	5mg/kg every 8 weeks
Golimumab (IV for PsA)	Intravenous	2mg/kg over 30 minutes at Weeks 0 and 4	2mg/kg every 8 weeks
Certolizumab	Subcutaneous (Lyophilized)	400mg at Weeks 0, 2, and 4;	400mg every 4 weeks or 200mg every 2 weeks (for PsA); 400mg every 2 weeks (for PsO)
Secukinumab (IV)	Intravenous	6mg/kg as a loading dose	1.75mg/kg every 4 weeks (max dose 300mg)